The chick embryo represents an accessible and economical in vivo model, which has long been used in developmental biology, gene expression analysis, and loss/gain of function experiments. In the present study, we assessed and characterized bone marrow derived mesenchymal stem cells from prenatal day 13 chicken embryos (chBMMSCs) and determined some novel properties. After assessing the mesenchymal stem cell (MSC) properties of these cells by the presence of their signature markers (CD 44, CD 73, CD 90, CD 105, and vimentin), we ascertained a very broad spectrum of multipotentiality as these MSCs not only differentiated into the classic tri-lineages of MSCs but also into ectodermal, endodermal, and mesodermal lineages such as neuron, hepatocyte, islet cell, and cardiac. In addition to wide plasticity, we detected the presence of several pluripotent markers such as Oct4, Sox2, and Nanog. This is the first study characterizing prenatal chBMMSCs and their ability to not only differentiate into mesenchymal lineages but also into all the germ cell layer lineages. Furthermore, our studies indicate that prenatal chBMMSCs derived from the chick provide an excellent model for multi-lineage development studies because of their broad plasticity and faithful reproduction of MSC traits as seen in the human. Here, we also present evidence for the first time that media derived from prenatal chBMMSC cultures have an anti-tumorigenic, antimigratory, and pro-apoptotic effect on human tumors cells acting through the Wnt-ß-catenin pathway. These data confirm that chBMMSCs are enriched with factors in their secretome that are able to destroy tumor cells. This suggests a commonality of properties of MSCs across species between human and chicken.
Introduction
Bone marrow derived mesenchymal stem cells (BMMSCs) can be differentiated into distinct skeletal tissues both in vitro and in vivo. Understanding the molecular mechanisms controlling stem cell differentiation is imperative for further progress in tissue and organ regeneration. The chicken embryo has traditionally been a favorite model of developmental biologists and cancer biologists, and has been used a platform to study stem cell implantation and differentiation in vivo. Being a versatile animal model, the chicken embryo has been used extensively for xenotransplantation studies of human stem cells from multiple sources. Human dental pulp stem cells, after transplantation into the mesencephalon region of the chicken embryo, expressed neuronal markers and acquired typical neuronal morphology [1] . Similarly, human-derived hematopoietic stem cells [2] , olfactory mucosa stem cells [3] , embryonic stem cells [4] , and mesenchymal stem cells [5] have been shown to differentiate into multiple lineages when transplanted into the chicken embryo. In addition, the chicken embryo has also been used to study cell-to-cell interactions between human skin-derived stem cells and glioma cells [6] . Thus, the success of using the chicken embryo as an efficient xenotransplantation platform for studying human stem cell biology can be attributed to easy handling, accessibility to surgical implantation methods, and a lack of an advanced immune system. Khatri et al. [7] characterized chicken lung mesenchymal stromal cells and studied their susceptibility to avian influenza virus. A genetic marker, namely, deleted-in-azoospermia-like (DAZL), was conserved in primordial germ cells (PGCs) and during germ-line differentiation until the adult stage, making them a valuable molecular marker for studies of PGC differentiation and germ-line development in the chicken [8] . However, the earliest MSCs to have been studied from the chicken are neonatal BMMSCs from 1-14 day old chickens [7] . A comprehensive study of the BMMSCs from chicken embryos has not been performed so far. Therefore, in this study we not only profiled the characteristic stem cell features of BMMSCs derived from prenatal chicken embryos (chBMMSCs), but also explored their plasticity in order to evaluate the plethora of lineages into which stem cells obtained from an early developmental stage can transform. We also identified a very interesting property of anti-tumorigenicity in these chBMMSCs. This study will help in validating chickderived prenatal stem cells as a highly robust and flexible platform for multiple lineage commitment and differentiation studies.
Methods

Isolation and Expansion of chBMMSCs
Chick embryos of 12-13 days (obtained from Veterinary College, Bangalore, India, after approval by the Institutional Ethics Committee) were opened from the shell, and bone marrow was collected from the femur by flushing with stem cell growth medium containing DMEM with high glucose (Gibco) supplemented with 1X GlutaMAX (Life Technologies), 10 % Fetal Bovine Serum (FBS) (Hyclone), and 100U/mL PenStrep (Life Technologies) using a sterile syringe. The aspirated bone marrow cells were centrifuged twice at 1,500 rpm for 10 min in fresh growth medium, and plated at a density of 1×10 6 cells/ml. The cultures were incubated at 37°C in a humidified atmosphere containing 5 % CO 2 . The floating cells were initially removed at intervals of 12-24 h and the cells were characterized for the colony forming ability typical of mesenchymal stromal cells. The colony forming units (CFUs) were identified by staining with 0.1 % crystal violet, and culture medium was changed every day until confluence was reached. Expansion of chBMMSCs was performed as previously reported for MSCs derived from the human amniotic membrane [9] . Briefly, after reaching confluence, P0 cells were trypsinized using 1 % trypsin-EDTA (Invitrogen) and the cells were passaged till P4 to obtain a homogenous population. The cells at P3 were characterized further and used for subsequent experiments.
Growth Curve Analysis and Population Doubling Time
Chick BMMSCs at p3 were plated at 1,000 cells/well in a 96 well plate and a growth curve was determined by using an MTT assay (Trevigen) at different time points (1, 2, 3, 4, and 5 days). From the growth curve, the population doubling time was determined [10] .
Multi-Lineage Differentiation
At the third passage, chBMMSCs were induced to differentiate into the classic tri-lineage of MSCs; namely osteogenic, adipogenic, and chondrogenic, and into the representative lineages of the three germ layers; namely neuronal, cardiac, hepatic, and islet cell using previously described protocols as follows.
Adipogenesis induction medium contained 1 μmol/L dexamethasone (Sigma-Aldrich), 10 μg/ml insulin (Clonetics), and 100 μmol/L indomethacin (Sigma-Aldrich) [11] . Osteogenesis induction medium consisted of 0.1 μmol/L dexamethasone (Sigma-Aldrich), 0.2 mmol/L ascorbic acid (Clonetics), and 10 mmol/L glycerol 2-phosphate (SigmaAldrich) [12] . Chondrogenesis was induced by 0.2 mmol/L ascorbic acid 2-phosphate solution (Clonetics), 0.1 μmol/L dexamethasone (Sigma-Aldrich), 0.1 mmol/L non-essential amino acid (Hi-Media), and 1 mM sodium pyruvate (SigmaAldrich) [13] . Within 2-3 days, morphological changes into the tri-lineages were observed and adipocytes, osteocytes, and chondrocytes were fixed and stained with Oil Red O Solution (0.5 %), Von Kossa Solution (2.5 %), and 1 % Alcian Blue solution (all from Sigma-Aldrich) respectively and visualized under a bright field phase contrast microscope (Nikon-Eclipse TE 2000-S). Photographs were taken using Qimaging-QICAM-fast 1394.
Hepatogenic differentiation was performed by treating chBMMSCs with hepatic induction medium consisting of 20 ng/mL bFGF (Clonetics), 0.5 μM dexamethasone (Sigma-Aldrich), and 50 mg/mL insulin transferrin selenium (ITS) (Invitrogen) [14] . Islet differentiation was performed according to a reported protocol [15] wherein induction medium consisted of 10 mM nicotinamide (Sigma-Aldrich), 2.5 mM mercaptoethanol (Sigma-Aldrich), and 2.5 mM glucose (Hi-media). Neuronal induction was performed using 10 ng/ml bFGF (Clonetics) [16, 17] , 0.5 μM retinoic acid (Sigma-Aldrich), and 1 mM ß-mercaptoethanol (SigmaAldrich). Cardiac differentiation was achieved using an induction medium containing 10 μm 5-azacytidine [18] . In all cases, the morphological changes appeared within 3-4 days.
Hepatic cells and islets were fixed and stained with 0.5 % Periodic acid-Schiff stain (PAS) and 100X Dithiazone (DTZ) (Sigma-Aldrich) respectively, and visualized under a bright field phase contrast microscope (Nikon-Eclipse TE 2000-S). Neuronal and cardiac cells were fixed for immunolocalization using mAbs for Nestin (1:250 dilution) and GATA4 (1:250 dilution) (BD Biosciences) respectively.
Immunocytochemistry
Cells from passage P3 were grown in 4-chambered slides and fixed using 4 % paraformaldehyde for 20 min at 4°C, and blocked with 3 % bovine serum albumin (BSA) in PBS for 30 min at room temperature. The cells were then incubated for 1 h in dark conditions at 4°C with primary non-labeled mouse anti-human antibodies against vimentin, CD 73, ß-3-tubulin, insulin receptor, troponin I, GATA4, Oct4, and Sox2 (1:250 dilutions, BD Biosciences) followed by anti-mouse rabbit fluorescein isothiocyanate (FITC) or phycoerythrin (PE) labeled secondary antibodies (1:250 dilutions, Invitrogen) for 1 h at 37°C. An additional step was included for staining the intracellular, nuclear, or cytoskeletal markers (vimentin, ß-3-tubulin, insulin receptor, Troponin T, GATA4, Oct4, and Sox2) by washing the cells with PBS containing 0.05 % Tween-20 along with the treatment of cells using 3 % BSA containing 0.1 % Triton X 100 for 30 min at room temperature to ensure that cell permeability was achieved. The nuclear stain 4′ ,6-diamidoino-2-phenylindole (DAPI) (1:10,000 dilution) was used for n u cl e ar v i s u al i z a t i o n a n d a d r o p o f an t i -f a d e (Vectashield; Vector Laboratory, Burlingame CA, USA) was added to avoid quenching of the fluorochrome before placing the cover slip. The slides were visualized using a Nikon Eclipse TE2000-U fluorescent microscope and photographs were taken using Qimaging-QICAM-fast 1394.
Flow Cytometry
Chick BMMSCs at P3 were removed from the culture dish with 0.05 % Trypsin-EDTA, the cell suspension was centrifuged at 1,000 rpm for 10 min and washed twice with PBS. Cells were fixed in pre-chilled 70 % ethanol and incubated in mouse anti-human FITC labeled antibodies against CD73, CD90, and CD34 (1:100 dilution) (all antibodies were purchased from Becton Dickenson, San Diego, CA, USA) for 1 h on ice. The cells were acquired using BD-FACS Calibur flow cytometer with a 488 nm laser and data were analyzed by Cell Quest Software (Becton Dickinson, San Jose, CA, USA).
Semi-Quantitative Reverse Transcription-pcr RNA Isolation, cDNA Synthesis, and Quantitative Reverse Transcription PCR Total RNA was extracted from chBMMSCs and the human primary glioblastoma U87-MG cell line using the RNeasy Plus Mini kit (Qiagen) according to the manufacturer's instructions. One microgram of total RNA was reversetranscribed using SuperScript III First-Strand Synthesis System (Invitrogen, Carlsbad, CA). One microgram of total RNA was mixed with 1 μL Oligo dT (50 μM) and 1 μL of dNTP (10 mM) and made to 13 μL with DEPC treated water and heated at 65°C for 10 min, followed by incubation on ice. After primer hybridisation, 7 μL reaction volume containing 5X first strand buffer, RNase OUT (40U/μL), 0.1 M DTT, and Superscript III were added to the RNA and subjected to thermocycling (25°C, 5 min; 50°C, 60 min; 70°C, 15 min) in a Veriti 96 well thermal cycler (Applied Biosystems). Qualitative expression of chicken-specific mesenchymal stem cell markers, lineage differentiation markers, and apoptotic markers (primers from Sigma, sequence as indicated in Tables 1 and 2 ) were analyzed by PCR (95°C 30 s; annealing temperature, 30 s; 72°C 30 s for 40 cycles) in a Veriti 96 well thermal cycler. Products were separated by 1.5 % agarose gel electrophoresis and detected using ethidium bromide. Integrated density values (IDV) were calculated using Alpha manager.
Real-Time Quantitative Reverse Transcription-pcr
The qualitative results of mRNA expression were further quantified using iQ SYBR Green Supermix (Bio-Rad, Hercules, CA) in a real time PCR system. cDNAs and genespecific primers were mixed with 2X iQ SYBR Green Optical 8-Tube Strip. Fluorescence shift was observed using a 7500 Real-time PCR system (Applied Biosystems). Reaction parameters were 50°C for 2 min, 95°C for 10 min, followed by 40 cycles of 95°C for 15 s and 60°C for 1 min. The relative abundance of mRNAs was obtained using the comparative cycle threshold method and was normalized to the housekeeping control GAPDH. Results are also expressed as fold changes in the mRNA levels of a gene compared to the treated or untreated samples.
Anti-Tumorigenicity Analysis
MTT Assay The TACS MTT assay kit (R&D Systems) was used according to the manufacturer's protocol to measure cell metabolic viability. Conditioned medium of chBMMSCs (BMMSC-CM) was prepared by collecting the medium in which the cells were cultured at P0, P1, P2, and P3, and centrifuging at 1,500 rpm to remove cell debris. The medium was stored at −20°C till use. The U87 (U87-MG grade 4 glioblastoma) and Hep2 (Human Larynx carcinoma) cell lines were obtained from ATCC and cultured and maintained in DMEM/F-12 (Gibco) (1:1) containing 1X GlutaMAX (Life Technologies), 10 % Fetal Bovine Serum (Hyclone), and Human Sox2
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Human Nanog 100U/mL PenStrep (Life Technologies). Non-stem cell controls used were human fibroblasts and mouse embryonic fibroblasts obtained from primary cultures. 10,000 cells per well were plated in a flat-bottomed 96-well plate. After 12 h, they were given a medium change and chBMMSC conditioned medium from P0, P1, P2, and P3 was added to the plates and incubated for 24 h. Following treatment, cells were washed with 1X PBS and provided with 100uL of fresh basal medium (DMEM/F-12+DMEM-LG) along with 10uL of MTT. Samples were incubated for 3 h at 37°C and 5 % CO 2 . The dye was solubilized by the addition of 100uL detergent reagent and an overnight incubation in the dark at RT, and the plates were read at 595 nm using a Victor 3 Multilabel Plate Reader (Perkin-Elmer).
BrdU Assay Cancer cells were treated with BMMSC-CM as indicated previously. Cell proliferation was measured using the BrdU Cell Proliferation Assay Kit (Cell Signalling Tech Inc) according to the manufacturer's protocol. Plates were read at 450 nm using a Victor 3 Multilabel Plate Reader.
Caspase-3 Assay U87 cells were treated with BMMSC-CM as indicated previously. The activity of apoptosis-inducing caspase-3 was assayed using the EnzChek DEVD-CHO Caspase3 Assay Kit (Invitrogen), which provides a fluorescent substrate R110. The intensity of the fluorescence is correlated with an increase in caspase-3 activity. The fluorescence intensity was measured using a Victor 3 Multilabel Plate Reader at 485/535 nm (Ex/Em).
Western Blotting Protein expression levels of ß catenin, the downstream and central component of canonical Wnt signaling, was determined by Western blotting. After treatment of U87 cells with BMMSC-CM, total protein in each condition was isolated in RIPA buffer (Invitrogen) following the manufacturer's instructions. Western blots contained 40 ug of protein per lane on a 8 % Tris-glycine SDS-polyacrylamide gel.
Proteins were transferred to a PVDF membrane (GE, NJ, USA). Blots were blocked in PBS containing 5 % nonfat dry milk powder and incubated overnight at 4°C with either anti-human mouse ß-catenin mAbs 1:500 dilution (R & D Systems, MN, USA), or anti-human mouse phospho ß-catenin mAbs 1:500 dilution (R & D Systems, MN, USA) or antihuman mouse GAPDH mAbs 1:500 dilution (Millipore). Rabbit anti-mouse Horse Radish Peroxidase linked secondary antibodies (1: 3,000) were used to bind to the primary antibody. The blot was developed with enhanced chemiluminescence reagent (Pierce, IL) and images were captured using AlphaImager (CA, USA).
Wound Scratch Assay U87 cells were grown in 6-well plates at a density of 3×10 6 /mL, and a small linear scratch was created in the confluent monolayer by gently scraping with a sterile cell scraper as per standard methods [19] . Cells were extensively rinsed with medium to remove cellular debris and treated with BMMSC-CM at passage 2. The area of the wound at selected time points (0, 12, 24, and 48 h) was recorded to assess migration and wound healing using a bright field phase contrast microscope (Nikon-Eclipse TE 2000-S) and photographs were taken using Qimaging-QICAM-fast 1394. The experiments were repeated thrice.
In Vitro Angiogenesis Assay The effect of BMMSC-CM on capillary tube formation of U87 cells was investigated using an In-vitro angiogenesis assay kit (Millipore, USA) according to the manufacturer's instructions. The formation of capillary tubes by the glioma cell line U87 in Matrigel has been previously demonstrated [20] . Briefly, 10,000 cells/well were seeded on a ECMatrix gel pre-coated 96-well plate and treated with either control medium or BMMSC-CM. Before seeding, U87 cells were treated with either control medium or BMMSC-CM for 24 h, and equal numbers of cells were added for both control and BMMSC-CM U87 cells. To study for the disruption of the capillary tubes, U87 cells were first directly seeded in the ECMatrix in control medium. After the formation of capillary tubes after 8 h, medium was replenished either with control medium or BMMSC-CM. Capillary tube formation was quantified at 4, 8, 12, and 24 h by bright field phase contrast microscope (Nikon-Eclipse TE 2000-S) and photographs were taken using Qimaging-QICAM-fast 1394. The experiments were repeated thrice.
In Vitro Migration Assay Cell migration was analyzed using a Transwell Migration System (BD Biosciences). Briefly, U87 cells were plated into upper chambers (Transwells with 8.0 μm pore size) in normal U87 culturing medium. The lower compartment of the chamber contained regular medium or BMMSC-CM. The chambers were cultured at 37°C in 5 % CO 2 for 12 h. The filter membranes were removed and the cell migrated to the lower surface were fixed with 70 % ethanol and stained with H&E and visualized under a phase contrast microscope. The experiments were done in triplicates.
Statistical Analysis
Data represent mean and SE from experiments done in triplicate. Each experiment was repeated three times. A two-sided Student's t test was used to determine the significance of any differences. For all statistical analyses, the level of significance was set at a probability of <0.05 (* p value<0.05).
Results
Prenatal Chbmmscs Proliferate Rapidly and Express Characteristic MSC Markers
Primary cells isolated from the 13-14 day prenatal chick bone marrow adhered in large numbers and elongated after 12 h, and formed rapidly dividing colony forming units (CFUs) within 48 h (Fig. 1a) . Cells proliferated rapidly and doubled in their numbers from their initial seeding density within 24 h (Fig. 1b) . After about 2 days the cells exhibited characteristic fibroblastic morphology and obtained 90 % confluence. These cells were passaged up to P2 and were then analyzed for characteristic MSC markers by immunofluorescence, flow cytometry, and semi-quantitative PCR. They were positive for CD 73, CD 90, CD 105, and vimentin, but negative for CD34 and CD45 (Fig. 1c-e) .
ChBMMSCs are Able to Rapidly Differentiate Into Ectodermal, Mesodermal, and Endodermal Lineages
Upon induction with the respective factors, chBMMSCs underwent differentiation into the MSC tri-lineage of adipocyte, chondrocyte, and osteocyte cell types within 24 h (Figs. 2a, b , and c). These cells stained positively with oil red O stain for adipocytes (Fig. 2a) , saffranin orange for chondrocytes (Fig. 2b) , and silver stain for osteocytes (Fig. 2c) . Upon testing for differentiation into the nonmesenchymal lineages, they were found to efficiently differentiate into the endodermal lineages of hepatic and islet-like cell types ( Fig. 2d and e) . Hepatic differentiation was confirmed by morphology (Fig. 2d1 ) and the cells staining bright pink, showing positivity for Periodic Acid-Schiff (PAS) stain (Fig. 2d2) . Islet-like differentiation was determined morphologically by the appearance of islet-like clusters (Fig. 2e1) , immunohistochemical staining for insulin receptor (IR) (Fig. 2e2) , and DTZ-specific crimson red staining (Fig. 2e3) . Undifferentiated chBMMSCs did not stain for IR (Fig. 2e4) , confirming the absence of islet cells in the native chBMMSCs. The endodermal lineage differentiation was achieved as early as 48 h. Ectodermal lineage development was confirmed by neuronal differentiation in which the cells obtained neuronal morphology with elongated axons (Fig. 2f1 ) and stained positively for the neuronal marker ß-3 tubulin, as confirmed by immunohistochemistry (Fig. 2f2) . Undifferentiated chBMMSCs did not stain for ß-3 tubulin (Fig. 2f3) , confirming the absence of neuronal cells in the native chBMMSCs. Cardiac differentiation was confirmed by morphology (Fig. 2g1) , the presence of the early cardiac induction nuclear marker GATA4 (Fig. 2g2) , and the late cardiac structural marker, troponin I (Fig. 2g3) . Undifferentiated chBMMSCs did not stain for troponin I (Fig. 2g4) . Both neuronal and cardiac morphology was seen within 3 days of induction, indicating highly efficient plasticity of these MSCs. The ability to differentiate into neuronal, cardiac, hepatocyte, and islet cell types was confirmed by RT-PCR (Fig. 2h ) of specific markers; namely, glial fibrillary astrocyte protein (GFAP) for neuronal, α myosin heavy chain (MHC) for cardiac, GATA4 for hepatocyte, and Isl1 for islet cell differentiation.
chBMMSCs Express Pluripotency Markers
The early embryonic markers were identified by the localization of embryonic stemness-related transcription factors such as Oct4 and Sox2 in the nucleus (Fig. 3a1,  2 and b1, 2) . The mRNA expression of pluripotent markers Oct4, Sox2, and Nanog along with the characteristic MSC marker CD44 was confirmed by qPCR analysis (Fig. 3c) . This indicates that these MSCs are primitive and have still retained their pluripotent properties. Normal human fibroblasts, used as a negative control, did not express any pluripotent markers (Fig. 3c3) . In order to demonstrate the loss of pluripotency upon differentiation, we analyzed the expression of Oct4, Sox2, and Nanog, before and after differentiation to the adipogenic lineage. There was a clear loss of expression of these markers (Fig. 3c4) , confirming that these markers are only present in undifferentiated stem cells. In this study, we report for the first time the ability of secreted factors from chBMMSC culture media to inhibit tumor cell proliferation, migration, and angiogenesis. Conditioned medium of chBMMSCs (BMMSC-CM) at passage 2 was able to inhibit 50 % of the proliferation of the glioma cell line U87 as determined by MTT assay (Fig. 4a) . This inhibition was not seen when we used the conditioned media of normal human fibroblast cells or mouse embryonic fibroblasts (Fig. 4b) . This inhibitory effect was further confirmed using a BrdU assay, which indicated a marked reduction in newly synthesized DNA when U87 cells were grown in BMMSC-CM (Fig. 4d) . We wanted to investigate if the inhibition by BMMSC-CM could be seen in different tumor lines and tested its effects on the head and neck cancer line Hep2. Growth inhibition, studied by MTT and BrdU assays, was similar to that seen with U87 cells and, over a period of 48 h, Hep2 cellular growth was completely arrested (Figs. 4c and d) .
To analyze the action of this inhibition of BMMSC-CM, we examined the activity of apoptosis-inducing caspase 3, using a caspase-3 assay. Apoptosis was induced in U87 cells treated with BMMSC-CM, which was evidenced by increased caspase-3 activity (Fid 4e). Further, to obtain insights into the inhibitory mechanisms, we utilized activators of the Wnt-ß-catenin pathway. Lithium chloride, an inhibitor of GSK-3ß kinase and agonist Wnt3a, both activators of ß-catenin, abolished the inhibition by BMMSC-CM. Using an antibody against sFRP4, a known antagonist of Wnt-Frizzled-related binding protein (Frb) [21] , also increased proliferation of BMMSC-CM treated U87 cells (Fig. 4f) . These results clearly suggest that the mode of inhibition is through the Wnt-ß-catenin pathway.
Conditioned medium was seen to have classic antitumor activity as assessed by migration and angiogenesis assays. Migration of U87 cells, as assessed by a wound scratch assay, was inhibited by BMMSC-CM (Figs. 5a-d ). Even after 24 h, the wounded area was not covered when treated with chBMMSC conditioned medium (Fig. 5c) , and, after 48 h, the cells started undergoing apoptosis (Fig. 5d) . To further confirm inhibition of migration by BMMSC-CM, a migration assay was performed using a transwell migration system. We observed a marked inhibition of migration of U87 cells across the membrane by BMMSC-CM (Fig. 5e) , as observed by reduced H&E staining of the membrane in BMMSC-CM Fig. 2 (continued) treated wells in comparison to the control. Angiogenesis, the hallmark property of aggressive tumors, was studied using an in vitro angiogenesis assay (Figs. 6a-e) . The classic angiogenic ring formation by U87 cells was retarded by BMMSC-CM in which the cells formed clumps, even after 24 h incubation on an angiogenesis promoting matrix (Fig. 6e) . Additionally, angiogenic rings formed by U87 cells within 8 h were disrupted upon incubation with BMMSC-CM for 24 h (Fig. 6f) , demonstrating a clear inhibition of capillary tubes, whereas control medium further enhanced the tube formation after 24 h.
BMMSC Conditioned Media Inhibits Glioma Cells Acting Through the WNT-ß-Catenin Pathway
Expression of apoptotic genes and genes downstream of the Wnt-ß-catenin TCF-LEF axis were studied. qPCR analysis of downstream activators of TCF-LEF linked to apoptosis and proliferation (Bax, caspase-3, xIAP, p21, and CyclinD1), metastasis (MMP2), and angiogenesis (VEGF) was performed. Apoptotic markers, p21, Bax, and caspase 3 were induced in BMMSC-CM treated U87 cells (Figs. 7a, b) , whereas expression of angiogenic gene (VEGF), ECM specific gene (Figs. 7a, b) . A confirmatory role of ß-catenin being the target of inhibition by BMMSC-CM was provided by Western blot analysis, wherein ß catenin, although present in untreated U87 cells, was reduced in BMMSC-CM treated U87 cells. In contrast, inactive phospho ß-catenin was only detected in BMMSC-CM treated U87 cells, further confirming the role of ß-catenin in inhibition (Fig. 7c) .
Discussion
In this study, we have characterized chicken BMMSCs for the first time in their embryonic stage, that is, from prenatal bone marrow. We show that these MSCs are extremely pliable and plastic, and have a very high turnover rate. Unlike MSCs isolated from adult human tissues, chBMMSCs were able to differentiate into all lineages of the ecto-, meso-, and endodermal types at a very rapid rate upon induction. Furthermore, we provide evidence that the media in which these MSCs are grown have a potent anti-tumorigenic effect by promoting apoptosis. This is the first time that MSCs from a nonmammalian organism have been shown to possess an antitumorigenic potential, indicating that stem cells have a property to detect and curb uncontrolled proliferation, and that this is probably a universal feature of mesenchymal stem cells.
Bone marrow MSCs from the chick have been characterized initially from the 1-14 days old chicken [7] and from adult chicken [22] . MSCs from chick embryo bone marrow stromal cells have been demonstrated to differentiate into bone and cartilage tissue when grown in a three-dimensional polymer scaffold [23] . However, a broad differentiation potential and a pluripotentiality of early chick embryo BMMSCs has not been demonstrated so far. In our study, we have isolated BMMSCs from prenatal chicken and found them to have a very rapid turnover time of 24 h, which identifies these as one of the fastest proliferating MSCs [24] . This could be attributed to their stage in very early development during the process of organogenesis, when a high turnover of stem cells is required to build the organs for completing development. On further characterization of these MSCs, we found them to be completely similar to human BMMSCs in relation to their marker profile and stemness properties. This suggests that chBMMSCs are an attractive source of MSCs in which isolation and proliferation is extremely rapid and can be obtained with minimum ethical constraints in comparison to human tissues. Additionally, we also demonstrated that chBMMSCs could differentiate into a wide variety of cell types in addition to the classic tri-lineage of adipocyte, chondrocyte, and osteocyte cell types. These MSCs differentiated upon induction into all the lineages we tested; namely, neuronal, cardiac, hepatic, and islet-like cells. Their duration of induction was much shorter than previously reported for any MSCs, with most lineages showing the early differentiation markers within 3-4 days of induction. This extreme plasticity could be attributed to the early developmental stage from which they were obtained, a property which could be exploited for studying the molecular regulation of lineage differentiation using a short time span. Bone marrow derived MSCs are plastic entities equipped with the ability to adjust to new mircoenvironments. However, this ability is limited in the adult tissue and is mostly confined to differentiation into the classic tri-lineage of mesodermal types such as osteogenic, adipogenic, and chondrogenic [25] . The wide spectrum of differentiation ability exemplified by the embryonic BMMSC, which we observed in this study, suggests that they share a similarity to embryonic stem cells with respect to their plasticity. Furthermore, since these BMMSCs are obtained from an early developmental stage, they are still naïve to new environs and are not lineage imprinted as seen with mesenchymal stromal cells derived from adult tissues [26] . These chick BMMSCs could thus be used as an ideal model for testing developmental toxins affecting the differentiation process of neuronal, cardiac, and hepatic lineages.
In chick BMMSCs isolated from early neonates, a pluripotent nature has been attributed to these MSCs [7] . This corroborates well with our study wherein we demonstrate the nuclear localization of Oct4 and Sox2, and mRNA expression of these markers, together with Nanog and CD44, and the loss of the pluripotent markers upon differentiation. The expression of pluripotency markers is probably related to the fetal or prenatal stage from which they are isolated and which bears resemblance to the embryonic stem cells. In contrast, adult BMMSCs of chicken, dermal-derived chicken MSCs, MSCs derived from chicken umbilical cord Wharton Jelly [20, 27] , or human fibroblasts, as observed in our study, have not been shown to express pluripotency or embryonic markers. Pluripotent stem cells are capable of differentiating into all embryonic germ layers and pluripotentiality is characterized by the expression of key pluripotent markers Oct4, Sox2, and Nanog [28, 29] . These markers can be induced by reprogramming or can occur naturally as seen in embryonic stem cells (ESCs). The expression of key pluripotent genes in chick embryonic BMMSCs, as seen in our study, further strengthens the notion that these stem cells are similar to ESCs. Detailed comparative studies between chick embryo BMMSCs and chick ESCs will throw light on the degree of pluripotentiality of these two stem cell types.
Some of the most attractive properties of MSCs are their inherent ability to track tumor cells [30] and their innate antineoplastic properties [31] . Our observation of the anti-tumor ability of chBMMSCs further confirms another property of MSCs, i.e. the ability to secrete factors that are apoptotic to tumor cells. Thus, the chBMMSC secretome is enriched with anti-proliferative, anti-migratory, and pro-apoptotic factors that act against tumors. This effect of MSCs isolated from prenatal chicks may be significant in the context of the microenvironment of the source of these MSCs. Tumors are not common in the early embryo, suggesting that the embryonic microenvironment, although containing actively proliferating and actively differentiating cells, is non-permissive for tumors. Joel et al., [32] have studied the behavior of human glioblastoma multiforme (GBM) cells in the embryonic tissue microenvironment of the chicken embryo. They found that glioma stem cells enriched from GBM exhibited reduced proliferation and survival, altered gene expression, and did not form tumors within the proliferative embryonic neural tissue. Following a recent report [33] , in which the Wnt antagonist DKK1 was shown to inhibit the anti-tumor property of human MSCs, we explored the role of the Wnt-ß-catenin axis in the tumor inhibitory properties of chick BMMSC-CM. At the extracellular level of the Wnt-ß-catenin pathway, addition of the Wnt agonist Wnt 3a, an antibody to the Wnt antagonist sFRP4, and using lithium chloride, the inhibitor of GSK3-ß (required for the phosphorylation of the cytosolic activator of Wnt, i.e., ß-catenin) were able to abolish inhibition. Further, active ß-catenin was reduced and inactive phospho ß-catenin was only observed in the BMMSC-CMtreated U87 cells. Addition of BMMSC-CM also led to the inhibition of the anti-apoptotic genes xIAP and cyclin D1, the angiogenic genes VEGF, the metastasis-associated gene MMP2, but resulted in upregulation of apoptotic genes, caspase-3, p21, and Bax. All these genes are associated downstream of the Wnt-ß-catenin pathway, thereby providing evidence that chick MSC-CM mediated anti-tumor activity could be regulated by Wnt pathway associated genes. Inhibition of angiogenesis of U87 cells by BMMSC-CM also showed clearly an innate tumor non-permissive ability. In addition, we demonstrate a marked suppression of migration of U87 cells by chick BMM-CM in an in vitro migration assay to provide further evidence of an anti-tumor ability of chick BMMSC-CM. Further confirmation of the anti-proliferative effect using a head and neck tumor cell line, suggests that BMMSC-CM inhibition could be effective across multiple types of tumors.
Therefore, chBMMSCs isolated from prenatal bone marrow could also have an innate tumor non-permissive ability that is inhibitory to glioma cells, thereby preventing their proliferation and migration (as seen in the wound scratch assay), and resulting in an increase of apoptotic markers (p21 and Bax) and a decrease in the oncogenic marker, CycD1.
Thus, from the observations in this study, we conclude that BMMSCs derived from prenatal chicken can be used as an easily available and rapidly proliferating stem cell platform to explore factors contributing to pluripotency, stemness, and regulation of multi-lineage differentiation. The antitumorigenic potential of the secreted factors from chBMMSCs needs to be further characterized to develop an effective therapeutic against glioblastoma. 
